v3.25.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (2,420,000) $ (1,076,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 288,000 423,000
Noncash lease expense 22,000
Depreciation expense 1,000
Change in fair value of common warrants classified as a liability (584,000) (1,362,000)
Changes in operating assets and liabilities:    
Accounts receivable (199,000)
Prepaid expenses (149,000) (53,000)
Other current assets (141,000) (26,000)
Deferred offering costs (27,000)
Accounts payable 381,000 (206,000)
Accrued expenses (580,000) 123,000
Net cash used in operating activities (3,381,000) (2,204,000)
Cash flows from investing activities:    
Purchase of property and equipment (2,000)
Net cash used in investing activities (2,000)
Cash flows from financing activities:    
Proceeds from equity financing, net of issuance cost 10,803,000
Proceeds from private placement offering, net of offering costs 5,378,000
Proceeds from exercise of stock options 8,000 42,000
Net cash provided by financing activities 10,811,000 5,420,000
Net increase in cash and cash equivalents 7,428,000 3,216,000
Beginning of period 7,154,000 1,173,000
End of period 14,582,000 4,389,000
Supplemental Disclosure of Cash Flow Information:    
Cash paid for income taxes 1,000
Cash paid for interest 5,000
Supplemental Disclosure of Noncash Financing Activities:    
Fair value of common warrant classified as a liability $ 1,928,000

Source

PDF HTML 10-Q Filing
ZIP XLS XBRL